Open Internet by MindsNet

Underrepresentation in Genomic Drug Safety Research

The majority of global drug safety genomic research is based on European populations, leading to a lack of representation for other populations and potential safety issues. This underrepresentation causes drugs to be prescribed without proper adjustment, resulting in adverse reactions. The issue affects individuals from various ethnic backgrounds, including those from Indian, African, and East Asian populations.

Science, Medicine, Pharmacology